Comments on "Systemic exposure of oxaliplatin and docetaxel in gastric patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy"

被引:0
|
作者
de Jong, Loek A. W. [1 ]
van Erp, Nielka P. [1 ]
de Reuver, Philip R. [2 ]
机构
[1] Radboud Inst Hlth Sci, Radboudumc, Dept Pharm, POB 9101, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Inst Hlth Sci, Radboudumc, Dept Surg, POB 9101, NL-6500 HB Nijmegen, Netherlands
来源
EJSO | 2021年 / 47卷 / 05期
关键词
D O I
10.1016/j.ejso.2020.09.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1216 / 1217
页数:2
相关论文
共 50 条
  • [21] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis
    Lynne M.Ellison
    Yangao Man
    Alexander Stojadinovic
    Hongwu Xin
    Itzhak Avital
    ChineseJournalofCancerResearch, 2017, 29 (01) : 86 - 92
  • [22] Exposure to Neoadjuvant Oxaliplatin Containing Chemotherapy, Does It Effect Intraperitoneal Hyperthermic Chemotherapy Perfusion?
    Mangieri, Christopher W.
    Valenzuela, Cristian D.
    Solsky, Ian B.
    Erali, Richard A.
    Votanopoulos, Konstantinos I.
    Shen, Perry
    Levine, Edward A.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 519 - 519
  • [23] Appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Randle, Reese W.
    Griffith, Kayla F.
    Fino, Nora F.
    Swett, Katrina R.
    Stewart, John H.
    Shen, Perry
    Levine, Edward A.
    Votanopoulos, Konstantinos I.
    JOURNAL OF SURGICAL RESEARCH, 2015, 196 (02) : 229 - 234
  • [24] Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: A single western center experience
    Scaringi, S.
    Kianmanesh, R.
    Sabate, J. M.
    Facchiano, E.
    Jouet, P.
    Coffin, B.
    Parmentier, G.
    Hay, J. M.
    Flamant, Y.
    Msika, S.
    EJSO, 2008, 34 (11): : 1246 - 1252
  • [25] Perioperative systemic chemotherapy in peritoneal carcinomatosis of lymph node positive colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Kuijpers, A. M.
    Mehta, A. M.
    Boot, H.
    van Leerdam, M. E.
    Hauptmann, M.
    Aalbers, A. G.
    Verwaal, V. J.
    ANNALS OF ONCOLOGY, 2014, 25 (04) : 864 - 869
  • [26] Peritoneal carcinomatosis in patients with gastric cancer, and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy
    Kim, Ki Won
    Chow, Oliver
    Parikh, Kunal
    Blank, Sima
    Jibara, Ghalib
    Kadri, Hena
    Labow, Daniel M.
    Hiotis, Spiros P.
    AMERICAN JOURNAL OF SURGERY, 2014, 207 (01): : 78 - 83
  • [27] Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy
    Verwaal, VJ
    van Tinteren, H
    van Ruth, S
    Zoetmulder, FAN
    BRITISH JOURNAL OF SURGERY, 2004, 91 (06) : 739 - 746
  • [28] Rate and extent of oxaliplatin absorption after hyperthermic intraperitoneal administration in peritoneal carcinomatosis patients
    Carlos Pérez-Ruixo
    José E. Peris
    Vanesa Escudero-Ortiz
    Pedro Bretcha-Boix
    José Farré-Alegre
    Juan José Pérez-Ruixo
    Belén Valenzuela
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 1009 - 1020
  • [29] Urinary tract surgery in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy
    Antonio Cascales, Pedro
    Gil, Jose
    Moreno Alarcon, Cristobal
    Galindo, Pedro
    Gomez, Guillermo
    Parrilla, Pascual
    CIRUGIA ESPANOLA, 2012, 90 (03): : 162 - 168
  • [30] Rate and extent of oxaliplatin absorption after hyperthermic intraperitoneal administration in peritoneal carcinomatosis patients
    Perez-Ruixo, Carlos
    Peris, Jose E.
    Escudero-Ortiz, Vanesa
    Bretcha-Boix, Pedro
    Farre-Alegre, Jose
    Jose Perez-Ruixo, Juan
    Valenzuela, Belen
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (05) : 1009 - 1020